25/04/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
April 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Mar
May »
25/04/2024
Apr 25, 2024, 21:38 |
Blog
Julie Gralow: Busy couple of days on the Hill at ASCO advocacy summit
Julie Gralow recently shared on X/Twitter: ''Busy couple of days on the Hill at ASCO…
Apr 25, 2024, 21:35 |
Opinion
Vincent Rajkumar: 10 suggested action items for physician colleagues
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, shared on X/Twitter: ''10 suggested action items for…
Apr 25, 2024, 21:33 |
Blog
C. Ola Landgren: It was an honor to present the EVIDENCE meta-analysis at ODAC
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Apr 25, 2024, 21:30 |
Blog
Anushka Dongre: Read more about Jason Luke’s work in cancer immunology
Anushka Dongre, Assistant Professor at Cornell University, shared a post on AACR Cancer Immunology Working…
Apr 25, 2024, 21:28 |
Blog
Libia Scheller: So honored to be part of this year’s celebration of eMerge Americas
Libia Scheller, Global Head of Oncology- Cooperative Groups and Strategic Alliances at Bayer HealthCare, shared a post on…
Apr 25, 2024, 21:25 |
Insight
Paper summary by Erman Akkus on TORCH
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Deep-learning method…
Apr 25, 2024, 21:12 |
Blog
Sumanta K. Pal: World class agenda with terrific speakers
Sumanta K. Pal, Professor and Vice Chair of Academics Affairs at City of Hope shared a…
Apr 25, 2024, 21:09 |
Insight
Piotr Wysocki: Salvage re-irradiation is a feasible option in locally recurrent prostate cancer after primary curative radiotherapy
Piotr Wysocki recently shared on LinkedIn: "Locally recurrent prostate cancer (PC) in patients who underwent primary…
Apr 25, 2024, 21:06 |
Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
Apr 25, 2024, 20:59 |
Societies
The official opening of the OncoDaily Leukemia Conference took place at the Yeolyan Hematology and Oncology Center
"Today, the official opening of the OncoDaily Leukemia Conference took place at the Yeolyan Hematology…
1
2
3
4
5
All:
62
Posts:
1 - 10
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube